Exhibits
20-F
from 20-F
98 pages
20-F
03/06/20
EX-2.1
from 20-F
1 page
Description of Rights of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 Our Authorized Capital Consists of an Unlimited Number of Common Shares. the Following Is a Summary of the Provisions Attached to Our Common Shares
03/06/20
EX-4.1
from 20-F
11 pages
Employment Agreement
03/06/20
EX-4.2
from 20-F
2 pages
Amending Agreement No. 1 This Amending Agreement Made Effective as of the 1st Day of December, 2015. Between: Oncoylytics Biotech Inc., ("Oncolytics") - And - Allison Hagerman
03/06/20
EX-4.3
from 20-F
11 pages
Employment Agreement
03/06/20
EX-4.6
from 20-F
38 pages
Employment Agreement
03/06/20
EX-4.7
from 20-F
2 pages
Amending Agreement
03/06/20
EX-4.8
from 20-F
12 pages
Executive Employment Agreement
03/06/20
EX-4.9
from 20-F
12 pages
Executive Employment Agreement
03/06/20
EX-4.10
from 20-F
2 pages
Amending Agreement #3
03/06/20
EX-4.11
from 20-F
2 pages
Amending Agreement #4
03/06/20
EX-4.12
from 20-F
2 pages
Amending Agreement #1
03/06/20
EX-4.13
from 20-F
2 pages
Amending Agreement
03/06/20
EX-4.14
from 20-F
2 pages
Amending Agreement #1
03/06/20
EX-4.15
from 20-F
2 pages
Amending Agreement #1
03/06/20
EX-8.0
from 20-F
1 page
Subsidiaries
03/06/20
EX-12.1
from 20-F
~1
page
Management certification
03/06/20
EX-12.2
from 20-F
~1
page
Management certification
03/06/20
EX-13.1
from 20-F
1 page
Management certification
03/06/20
EX-13.2
from 20-F
1 page
Management certification
03/06/20
EX-15.1
from 20-F
27 pages
Additional exhibits
03/06/20
EX-15.2
from 20-F
1 page
Additional exhibits
03/06/20
